NanoMosaic

Nano-scale molecular profiling, screening and discovery

Woburn, United States · Founded 2018 · $40.8M raised

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$40.8M
Last Round
$40.8M Series ADec 2021
Rounds
1

About

NanoMosaic is a Boston-area biotechnology company developing a next-generation protein interrogation platform powered by proprietary nanoneedle technology licensed from Harvard University. The company's MosaicNeedles™ platform enables high-throughput, ultrasensitive detection and quantification of proteins, nucleic acids, and other analytes on a single chip, supporting early disease detection, prognostic monitoring, and biomarker discovery. NanoMosaic's tools are designed for researchers in oncology, neurology, and gene therapy, offering a workflow that integrates seamlessly with existing laboratory processes. The platform has been applied to developing clinical biomarker tests for conditions including cancer and neurological diseases.

Summary

NanoMosaic is a Life Sciences company based in Woburn, United States, founded in 2018. It has raised $40.8M in total across 1 round, most recently a $40.8M Series A round in Dec 2021.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2021
$40.8M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NanoMosaic on Indexed.vc
<a href="https://indexed.vc/companies/nanomosaic"><img src="https://indexed.vc/api/badge/company/nanomosaic" alt="NanoMosaic on Indexed.vc" width="260" height="76" /></a>